myriad genetics stock analysis

Shares of Myriad Genetics MYGN 482 a genetic-testing and precision-medicine biotech company were down more than 24 this week as of Thursday according to data from. Is a genetic testing and precision medicine company.

Myriad Genetics Inc Mygn Stock Price Quote News Stock Analysis

MYGN stock analysis from Seeking Alphas top analysts.

. MYGN reported an adjusted loss per share EPS of 19 cents for the third quarter of 2022 significantly wider than the Zacks Consensus Estimate of a loss of 4 cents and the. A stocks market value is critical but the process. Revenue missed analyst estimates by 82.

Exclusive research and insights from bulls and bears. MYGN stock analyst estimates including earnings and revenue EPS upgrades and downgrades. See Myriad Genetics Inc.

The Myriad Genetics stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations Crowd Wisdom Hedge Fund Activity. Detailed financial statements for Myriad Genetics MYGN including the income statement balance sheet and cash flow statement. According to 14 stock analysts the average 12.

Myriad Genetics Inc. The Company primarily provides testing and collaborative development of testing that is designed. Myriad Genetics Revenues and Earnings Miss Expectations.

MYGN stock quote history news and other vital information to help you with your stock trading and investing. Myriad Genetics has a market cap or net worth of 163 billion as of October 28 2022 making it the 2076th biggest public company in the US. Myriad Genetics Inc a genetic testing and precision medicine company develops and commercializes genetic tests in the United States and internationally.

The price of a stock is the truest depiction of a companys value and what the market anticipates about its performance. Myriad Genetics Inc. The following Managements Discussion and Analysis of Financial Condition and Results of Operations should be read in conjunction with the unaudited Condensed.

Myriad Genetics Inc. On average during the next 3 years compared to a 15 growth forecast for the Biotechs industry in the US. Myriad Genetics Stock analysis including Myriad Genetics investment evaluation stock information alerts predictive tools such as market volatility and liquidity estimators and more.

MYGN IEX Real-Time Price USD. Earnings per share EPS also missed analyst estimates by 74. MYGN IEX Real-Time Price USD.

View stock price news on TradeStation to help you make better trading investing decisions. 3 Wall Street analysts have issued 12-month target prices for Myriad Genetics shares. Year 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 - 1996.

Looking ahead revenue is forecast to grow 66 pa. Find the latest analyst research for Myriad Genetics Inc. Myriad Genetics Stock Down 69 The company has a market capitalization of 131 billion a PE ratio of -6808 and a beta of 171.

Myriad Genetics MYGN Financial Ratios and Metrics Stock Analysis. Find the latest Myriad Genetics Inc. MYGN stock forecast based on top analysts estimates plus more investing and trading data from Yahoo Finance.

Their MYGN share price forecasts range from 2200 to 3200. The firm has a 50-day moving average of. Myriad Geneticss market cap has decreased by.

Find the latest Myriad Genetics Inc. Find the latest Myriad Genetics Inc. Myriad Genetics MYGN.

Mygn Myriad Genetics Inc Stock Overview U S Nasdaq Barron S